文献速递泌尿生殖腹部MR

输尿管口膀胱肿瘤的多参数MRI评估VI-RADS

Multiparametric MRI Evaluation of VI-RADS for Bladder Tumors Located at the Ureteral Orifice.
PubMed 文献 · Radiology · 2022-06-07

本回顾性研究纳入2012年1月至2021年11月组织病理确诊的输尿管口膀胱癌患者78例,由两名影像科医生独立依据VI-RADS对多参数MRI评分。VI-RADS预测肌层浸润的AUC为0.96(95%CI:0.92,1.00),各评分对应肌层浸润率从VI-RADS 1的0%递增至VI-RADS 5的100%。

要点

  • 输尿管口膀胱肿瘤中,VI-RADS 3分者83%存在肌层浸润,VI-RADS 4分和5分者肌层浸润率均为100%。
  • VI-RADS预测输尿管口膀胱肿瘤肌层浸润的AUC为0.96(95%CI:0.92,1.00)。
  • 两名影像科医生独立评分,采用加权κ分析评估观察者间一致性。

核心结论

  • 基于多参数MRI的VI-RADS可准确预测输尿管口膀胱肿瘤的肌层浸润。

研究设计与样本

  • 回顾性研究纳入2012年1月至2021年11月组织病理确诊的输尿管口膀胱癌患者78例(平均年龄67岁±7[SD],年龄范围46-90岁,67例男性),由两名盲法影像科医生独立依据VI-RADS对多参数MRI评分。

诊断标准与关键数值

  • 共识读时VI-RADS 1分1例(1%)、2分27例(35%)、3分6例(8%)、4分10例(13%)、5分34例(44%);与组织病理对照,肌层浸润存在率VI-RADS 1为0%(0/1)、2为15%(4/27)、3为83%(5/6)、4为100%(10/10)、5为100%(34/34);VI-RADS检测肌层浸润性膀胱癌的AUC为0.96(95%CI:0.92,1.00)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background The Vesical Imaging Reporting and Data System (VI-RADS) based on multiparametric MRI scans standardizes preoperative bladder cancer staging. However, limitations have been reported for VI-RADS, particularly for ureteral orifice tumors. Purpose To investigate the diagnostic performance and interobserver agreement of VI-RADS in evaluating muscle invasion for bladder tumors located at the ureteral orifice. Materials and Methods In this retrospective study, patients with histopathologically confirmed bladder cancer occurring at the ureteral orifice from January 2012 to November 2021 were analyzed. Two blinded radiologists independently scored multiparametric MRI scans according to VI-RADS. Interobserver agreement of the VI-RADS scores was evaluated with weighted κ analysis. Receiver operating characteristic curve analysis was used to evaluate the diagnostic performance of the VI-RADS scores in the prediction of muscle invasion. Results A total of 78 patients (mean age, 67 years ± 7 [SD]; age range, 46-90 years; 67 men) were included in the final analysis: 25 with non-muscle-invasive bladder cancer and 53 with muscle-invasive bladder cancer (MIBCa). At consensus reading, one (1%) case was scored as VI-RADS 1, 27 cases (35%) were scored as VI-RADS 2, six (8%) were scored as VI-RADS 3, 10 (13%) were scored as VI-RADS 4, and 34 (44%) were scored as VI-RADS 5. On comparison of the VI-RADS score with histopathologic findings, it was confirmed that the presence of muscle invasion was 0% (zero of one) for VI-RADS 1, 15% (four of 27) for VI-RADS 2, 83% (five of six) for VI-RADS 3, 100% (10 of 10) for VI-RADS 4, and 100% (34 of 34) for VI-RADS 5. The area under the receiver operating characteristic curve of VI-RADS in the detection of MIBCa was 0.96 (95% CI: 0.92, 1.00). Conclusion The Vesical Imaging Reporting and Data System could be used to accurately predict muscle invasion for bladder tumors occurring at the ureteral orifice. © RSNA, 2022 Online supplemental material is available for this article.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Cai, Ling, Kong, et al. Multiparametric MRI Evaluation of VI-RADS for Bladder Tumors Located at the Ureteral Orifice. Radiology. 2022. PMID: 35670714. doi:10.1148/radiol.220028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。